🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a two-part study to be conducted at a single study site in the US. ...
Status
Completed
Location
PPD Development, LP
Start Date
2016-07
Trial ID
NCT02820935
Treatments Being Tested
This is a multi-institution, open label, phase I/II study of Iberdomide, Ca...
Status
Suspended
Location
Lombardi Comprehensive Cancer Center
Start Date
2022-05-13
Trial ID
NCT05199311
Treatments Being Tested
This is a Phase 1b/2 randomized study of Iberdomide (CC-220) added to 3 dif...
Status
Withdrawn
Location
Beth Israel Deaconess Medical Center
Start Date
2021-10-10
Trial ID
NCT04882163
This Phase 1/2, multicenter, open-label study to evaluate CC-220 alone, as ...
Status
Terminated
Location
Local Institution - 106
Start Date
2020-11-11
Trial ID
NCT04464798
Treatments Being Tested
Similar to the paradigm established in other hematologic malignancies that ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-01-18
Trial ID
NCT05434689
Treatments Being Tested
This study is to evaluate the combination of isatuximab, iberdomide, bortez...
Status
Not Yet Recruiting
Location
Beth Israel Deaconess Medical Center (BIDMC)
Start Date
2026-06-26
Trial ID
NCT07601100
Treatments Being Tested
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2012-11-01
Trial ID
NCT01733875
Treatments Being Tested
This is a phase II study to evaluate the efficacy and safety of different d...
Status
Active Not Recruiting
Location
Centre Hospitalier Universitaire de Bordeaux
Start Date
2021-02-22
Trial ID
NCT04564703
Treatments Being Tested
The purpose of this study is to determine whether CC-220 is effective for t...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-09-16
Trial ID
NCT02185040
This is a single-arm, open-label study evaluating the safety, tolerability ...
Status
Active Not Recruiting
Location
Icahn School of Medicine
Start Date
2023-02-06
Trial ID
NCT05560399
Treatments Being Tested